ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
Based on recent data, BeOne Medicines Ltd. (ONC) shows an Average True Range (ATR) of 10.3 and an Enterprise Value of N/A. Its average trading volume over the past 3 months is 369.02K, indicating liquidity. These fundamental metrics provide insight into ONC's underlying financial health and market activity.
BeOne Medicines Ltd. (ONC) technical indicators as of August 11, 2025: the SMA 20 is -1.53%, SMA 50 at 6.91%, and SMA 200 at 22.89%. The RSI 14 value is 52.13, suggesting its current momentum. These technical analysis signals help assess ONC's price trends and potential future movements.
BeOne Medicines Ltd. (ONC) stock performance overview as of August 11, 2025: The 52-week high is $313.22 (currently -8.01% below), and the 52-week low is $170.99 (currently 68.54% above). Over the past year, ONC's performance is 73.96%, compared to the S&P 500's 20.13% change.
According to market data, BeOne Medicines Ltd. (ONC) stock's recent performance metrics show that over the last month, ONC is 13.73%, with a Year-to-Date (YTD) performance of 56.02%. Over the past year, the stock has seen a 73.96% change. These figures summarize ONC's price movements across various periods, reflecting its historical returns.
According to current financial data, ONC stock's P/E (TTM) ratio is -13.52, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for ONC, including P/S (6.95), P/B (0.64), and P/FCF (171.54), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep